GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

HALIFAX - Nova Scotia’s Progressive Conservatives say that if re-elected Nov. 26 they will introduce a universal shingles ...

Housing remained the focus of the NDP on Tuesday, as leader Claudia Chender promised to create a compliance and enforcement ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

Nova Scotia’s top party leaders are talking traffic congestion, seniors’ health and rental disputes as the provincial ...

More Torontonians will be able to get their doses of a new COVID-19 vaccine on Monday. Everyone who is at least six months ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the ... nanoparticle delivery platforms at the University of ...

A new variant of COVID called XEC — a combination of two Omicron subvariants — is spreading in the middle of flu season.

But the situation is much different in Nova Scotia. "At this point, it doesn't seem like we're going to be getting this vaccine," said Hannah Markham. "At least [not] any time soon." Markham ...

Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...

Two more cases of measles have been confirmed in New Brunswick, bringing the total number of cases to five. On Oct. 24, New ...